Investors

Genomic Vision is a publicly-traded company on the Euronext regulated market in Paris

 

 

Regulated Information

Financial Reports

2022

September 29, 2022: First Semester Financial Report on June 30 (French version)

Sept. 6, 2022: Genomic Vision announces the issuance of the 1st tranche of convertible notes with warrants (OCABSA) for €2 million, as part of the financing line concluded with Winance for a maximum amount of €30 million

July 18, 2022: Additional contribution to the liquidity contract concluded with CM-CIC Securities

July 7, 2022 : Bilan Semestriel du Contrat de liquidité contracté avec CM-CIC Securities (French version)

May 20, 2022 : Note d’opération OCABSA (French Version)

May 20, 2022 : Amendement du document d’enregistrement universel du 14 avril 2022. (French version)

April 28, 2022 : Rapport financier annuel 2021 (chapitre 5) French version

April 28, 2022 : Rapport financier annuel 2021 (sauf chapitre 5) French version

April 15, 2022: Information mise à disposition du document d’enregistrement universel French version

April 15, 2022: Document universel d’enregistrement (sauf Chapitre 5) French version.

April 15, 2022: Document universel d’enregistrement (Chapitre 5) French version 

Click here to access the French Documentation: “Suivi du programme d’Ocabsa avec Winance”

2021

Click here to access the French Documentation: Bilan semestriel du contrat de liquidité au 31 décembre 2021 

Click here to access the French documentation “Suivi du programme d’OCABSA avec Winance

Click here to access the French documentation “Rapport financier semestriel au 30 juin 2021”

Click here to access the French documentation “Suivi du programme d’OCABSA avec Winance

Click here to access the French documentation “Suivi du programme d’OCABSA avec Winance – 31/12/2020”

Click here to access the French documentation “Nombre total d’actions et de droits de vote – 31/12/2020”

Click here to access the French documentation “Rapport Financier Semestriel du 30 Juin 2020

Click here to access the French documentation  “Rapport Financier Annuel 2019

Status updated – July 2020

First Semester Financial Report 2019 (French)

Reference document 2018 (French) part 1 excl section 20.4 Financial statements French GAAP p234-266

Reference document 2018 (French) part 2 section 20.4 Financial statements French GAAP p234-266

First Semester Financial Report 2018 (French)

Annual Financial Report 2017 (French)

First Semester Financial Report 2017 (French)

Reference document 2016 (French)

First Semester Financial Report 2016 (French)

Annual Financial Report 2015 (French)

First Semester Financial Report 2015 (French)

Annual Financial Report 2014 (French)

First Semester Financial Report 2014 (French)

 


Monthly Statement

Information on December 31, 2019 (French)

 


Articles of association (French)


ABSA Prospectus (French)

> ABSA Prospectus – note d’opération (French)


 

IPO Prospectus (French)

Half-yearly report on the liquidity contract (French)

Rules of procedure of the supervisory board (French)

Press Releases

 

frise

 

genomic_web_visuels_footer_COMPANY